These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19046438)

  • 1. Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype.
    Sagvolden T; Dasbanerjee T; Zhang-James Y; Middleton F; Faraone S
    Behav Brain Funct; 2008 Dec; 4():56. PubMed ID: 19046438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat models of ADHD.
    Sagvolden T; Johansen EB
    Curr Top Behav Neurosci; 2012; 9():301-15. PubMed ID: 21487952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain.
    Sagvolden T; Johansen EB; Wøien G; Walaas SI; Storm-Mathisen J; Bergersen LH; Hvalby O; Jensen V; Aase H; Russell VA; Killeen PR; Dasbanerjee T; Middleton FA; Faraone SV
    Neuropharmacology; 2009 Dec; 57(7-8):619-26. PubMed ID: 19698722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.
    Miller EM; Pomerleau F; Huettl P; Russell VA; Gerhardt GA; Glaser PE
    Neuropharmacology; 2012 Dec; 63(8):1327-34. PubMed ID: 22960443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing and delay discounting in attention-deficit/hyperactivity disorder: A translational approach.
    Fox AE; Nicholson AM; Singha D; Thieret BAS; Ortiz M; Visser EJ
    Dev Psychobiol; 2023 Jul; 65(5):e22399. PubMed ID: 37338253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus control in two rodent models of attention-deficit/hyperactivity disorder.
    Fox AE; Caramia SR; Haskell MM; Ramey AL; Singha D
    Behav Processes; 2017 Feb; 135():16-24. PubMed ID: 27864066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common prefrontal cortical gene expression profiles between adolescent SHR/NCrl and WKY/NCrl rats which showed inattention behavior.
    Dela Peña I; Bang M; Lee J; de la Peña JB; Kim BN; Han DH; Noh M; Shin CY; Cheong JH
    Behav Brain Res; 2015 Sep; 291():268-276. PubMed ID: 26048425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of motor activity in spontaneously hypertensive rats compared to Wistar Kyoto rats.
    Fasmer OB; Johansen EB
    Behav Brain Funct; 2016 Dec; 12(1):32. PubMed ID: 27906019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual variability (IIV) in an animal model of ADHD - the Spontaneously Hypertensive Rat.
    Perry GM; Sagvolden T; Faraone SV
    Behav Brain Funct; 2010 Oct; 6():56. PubMed ID: 20925933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral changes following PCB 153 exposure in the spontaneously hypertensive rat - an animal model of Attention-Deficit/Hyperactivity Disorder.
    Johansen EB; Fonnum F; Lausund PL; Walaas SI; Bærland NE; Wøien G; Sagvolden T
    Behav Brain Funct; 2014 Jan; 10():1. PubMed ID: 24405777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2011 Mar; 7():6. PubMed ID: 21450079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T; Xu T
    Behav Brain Funct; 2008 Jan; 4():3. PubMed ID: 18215285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autism-related behavioral phenotypes in an inbred rat substrain.
    Zhang-James Y; Yang L; Middleton FA; Yang L; Patak J; Faraone SV
    Behav Brain Res; 2014 Aug; 269():103-14. PubMed ID: 24780868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrsp Gene and the ADHD Predominantly Inattentive Presentation.
    Custodio RJP; Kim M; Chung YC; Kim BN; Kim HJ; Cheong JH
    ACS Chem Neurosci; 2023 Feb; 14(4):573-589. PubMed ID: 36716294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
    Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2006 Dec; 2():41. PubMed ID: 17173664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-fostering does not alter the neurochemistry or behavior of spontaneously hypertensive rats.
    Howells FM; Bindewald L; Russell VA
    Behav Brain Funct; 2009 Jun; 5():24. PubMed ID: 19549323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of SLC9A9 and interacting molecules in the hippocampus of rat models for attention deficit/hyperactivity disorder.
    Zhang-James Y; Middleton FA; Sagvolden T; Faraone SV
    Dev Neurosci; 2012; 34(2-3):218-27. PubMed ID: 22777493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
    Dela Peña I; Shen G; Shi WX
    Eur J Pharmacol; 2021 Feb; 892():173826. PubMed ID: 33347825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.